Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

Monoclonal antibodies are novel therapeutic agents ... difficulties since duration and severity of disease, concomitant medications and illnesses, dates of studies performed, inclusion/exclusion ...

With a growing list of regulatory approvals sparking sustained interest in producing monoclonal antibodies, Eppendorf has been supporting researchers who are working with both bacterial and ...

The results are in from the first monoclonal antibody drug for COVID-19 tested in humans. The small Phase 2 clinical trial involving 452 participants shows the drug can reduce the need for ...

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other ...

With over 80 publications, Mohta has expertise in the use of biological drugs for both cutaneous and systemic disorders. View Full Profile. Learn about our Editorial Policies. Scientists create ...

Monoclonal antibodies offer a major advantage in drug discovery, and it’s no longer difficult to quickly make a lot of new antibodies. But this leads to their biggest drawback. Screening and ...

An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha-gal syndrome, ...

Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new b ...